Sort
8,912 grants matching “sars cov 2”
Interventions that Retard Mammalian Aging
$121,763David E Harrison · Jackson Laboratory · U01 · FY2021 · AG
RAPID: Undergraduate Research in Modeling and Computation for Discovery of Molecular Probes for SARS-CoV-2 Proteins
$121,691Mary Jo Ondrechen · Northeastern University · · FY2020 · BIO
Genetic screens to find critical host factors for SARS-CoV-2 infection
$121,561Jan E Carette · Stanford University · R01 · FY2020 · AI
An OpenData Portal to share SARS-CoV-2 drug repurposing data in real time
$121,256Matthew Hall · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium
$121,192Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2025 · AI
Factors Influencing Pediatric Asthma into Adulthood (FIPA2)
$120,454Lyle G Best · Missouri Breaks Research, Inc. · R01 · FY2024 · MD
RFA-CK-22-008, TRANSMIT: Training Research Acumen in Students Modeling Infectious Threats
$120,415Lindsay T. Keegan · University Of Utah · U01 · FY2023 · CK
Understand the mechanism of SARS-CoV-2 entry by single-molecule approaches
$120,258Prakash Shrestha · University Of Kentucky · K25 · FY2025 · AI
Understand the mechanism of SARS-CoV-2 entry by single-molecule approaches
$120,258Prakash Shrestha · University Of Kentucky · K25 · FY2024 · AI
Clonal hematopoiesis and severity of COVID-19 disease
$120,235Kenneth Walsh · University Of Virginia · R21 · FY2022 · AG
Development of a SARS-CoV-2 vaccine
$120,218Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
DEVELOPMENT OF SINGLE DOMAIN ANTIBODY (SDAB) BASED THERAPEUTICS TARGETING SARS-COV-2 SPIKE PROTEIN FOR THE TREATMENT OF COVID-19
$120,137Inhibrx, Inc. · · FY2021 · Defense Health Agency
Admin-Core-001
$120,079Fred R Hirsch · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · CA
Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses
$120,079Fred R Hirsch · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · CA
Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases
$120,019H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Administrative Core
$119,921Fred R Hirsch · Icahn School Of Medicine At Mount Sinai · U54 · FY2024 · CA
Project 2: Susceptibility of Lung Cancer Cells to SARS- CoV-2 Infection and Antibody-Mediated Neutralization
$119,920Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U54 · FY2024 · CA
Project 1: Characterization of the Antibody Response to SARS-CoV-2 in Lung Cancer Patients
$119,920Florian Krammer · Icahn School Of Medicine At Mount Sinai · U54 · FY2024 · CA
Clinical Core
$119,920Philip C Mack · Icahn School Of Medicine At Mount Sinai · U54 · FY2024 · CA
Data Science COre
$119,920Yu Shyr · Icahn School Of Medicine At Mount Sinai · U54 · FY2024 · CA
IIBR:Informatics:RAPID: Structure-based identification of SARS-derived peptides with potential to induce broad protective immunity
$119,747Lydia Kavraki · William Marsh Rice University · · FY2020 · BIO
Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)
$119,719Sabra L Klein · Johns Hopkins University · U54 · FY2022 · CA
Admin-Core-001
$119,719Sabra L Klein · Johns Hopkins University · U54 · FY2022 · CA
Study of and development of antiviral drugs against SARS-CoV2 protease
$119,668Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Pathogenesis and immunity during SARS-CoV-2 infection
$119,564Julie Fox · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI